Tullman Stephen A. 4
4 · Aclaris Therapeutics, Inc. · Filed Apr 9, 2018
Insider Transaction Report
Form 4
Tullman Stephen A.
Director
Transactions
- Purchase
Common Stock
2018-04-06$16.54/sh+26,700$441,618→ 157,507 total
Holdings
- 394,014(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on March 23, 2018.
- [F2]This transaction was executed in multiple trades at prices ranging from $16.23 to $17.06, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]These shares are held by the 2007 Irrevocable Trust of Stephen A. Tullman, for which the reporting person's spouse serves as the trustee.